Compare · CDRE vs SNN
CDRE vs SNN
Side-by-side comparison of Cadre Holdings Inc. (CDRE) and Smith & Nephew SNATS Inc. (SNN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CDRE and SNN operate in Industrial Specialties (Health Care), so they compete in similar markets.
- SNN is the larger of the two at $13.00B, about 10.4x CDRE ($1.24B).
- SNN has hit the wire 6 times in the past 4 weeks while CDRE has been quiet.
- SNN has more recent analyst coverage (23 ratings vs 12 for CDRE).
- Company
- Cadre Holdings Inc.
- Smith & Nephew SNATS Inc.
- Price
- -
- -
- Market cap
- $1.24B
- $13.00B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NYSE
- NYSE
- IPO
- 2021
- News (4w)
- 0
- 6
- Recent ratings
- 12
- 23
Cadre Holdings Inc.
Cadre Holdings, Inc. manufactures and distributes safety and survivability equipment that provides protection to users in hazardous or life-threatening situations. It primarily provides body armor product, such as concealable, corrections, and tactical armor under the Safariland and Protech Tactical brands; survival suits, remotely operated vehicles, specialty tools, blast sensors, accessories, and vehicle blast attenuation seats for bomb safety technicians; bomb suits; duty gear, including belts and accessories; and other protective and law enforcement equipment. The company also offers third-party products, such as uniforms, optics, boots, firearms, and ammunition. It serves first responders, such as state and local law enforcement, fire and rescue, explosive ordnance disposal technicians, emergency medical technicians, fishing, and wildlife enforcement and departments of corrections, as well as federal agencies including the U.S. Department of State, U.S. Department of Defense, U.S. Department of Interior, U.S. Department of Justice, U.S. Department of Homeland Security, U.S. Department of Corrections, and various foreign government agencies internationally. The company was incorporated in 2012 and is headquartered in Jacksonville, Florida.
Smith & Nephew SNATS Inc.
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products for surgeons, including instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder, as well as meniscal repair systems. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, including biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.
Latest CDRE
- CEO AND CHAIRMAN Kanders Warren B sold $2,068,000 worth of shares (75,000 units at $27.57) (SEC Form 4)
- SEC Form 4 filed by Director Kissel Mary E.
- SEC Form 4 filed by Director Quigley William G Iii
- Amendment: SEC Form SCHEDULE 13D/A filed by Cadre Holdings Inc.
- SEC Form 4 filed by Director Norton Hamish
- SEC Form 4 filed by Director Sokolow Nicolas
- SEC Form 4 filed by CHIEF FINANCIAL OFFICER Browers Blaine
- SEC Form 4 filed by PRESIDENT Williams Brad
- SEC Form 4 filed by CEO AND CHAIRMAN Kanders Warren B
- CEO AND CHAIRMAN Kanders Warren B sold $6,539,000 worth of shares (225,000 units at $29.06) (SEC Form 4)
Latest SNN
- Smith+Nephew introduces groundbreaking LYNX™ COBLATION™ Laryngeal Wand for ENT surgeons
- New German expert consensus provides first risk-based recommendations for sNPWT use in closed surgical incisions
- New German expert consensus highlights role for NPWT in mitigating the economic impact of postoperative wound complications
- SEC Form 6-K filed by Smith & Nephew SNATS Inc.
- SEC Form 6-K filed by Smith & Nephew SNATS Inc.
- SEC Form 6-K filed by Smith & Nephew SNATS Inc.
- SEC Form 6-K filed by Smith & Nephew SNATS Inc.
- SEC Form 6-K filed by Smith & Nephew SNATS Inc.
- Fresh Off Its Nasdaq Debut, a Regenerative-Medicine Upstart Is Stacking Its Board With Big-Pharma Firepower
- SEC Form 6-K filed by Smith & Nephew SNATS Inc.